Can calcitonin gene-related peptide (CGRP) and pentraxin-3 (PTX-3) be useful in diagnosing acute migraine attack?

References

• Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia. 2018;38(1):1–211.
   PubMed Web of Science ®Google Scholar
• Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990e2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211–e1259.
   PubMed Web of Science ®Google Scholar
• Pearce JM. Historical aspects of migraine. J Neurol Neurosurg Psychiatry. 1986;49(10):1097–1103.
   PubMed Web of Science ®Google Scholar
• Qubty W, Patniyot I. Migraine pathophysiology. Pediatr Neurol. 2020;107:1–6.
   PubMed Web of Science ®Google Scholar
• Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartrate. Arch NeurPsych. 1938;39(4):737e763.
   Google Scholar
• Amin FM, Asghar MS, Hougaard A, et al. Magnetic resonance angiography of intracranial and extra-cranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol. 2013;12(5):454e461–454e461.
   Web of Science ®Google Scholar
• Rahmann A, Wienecke T, Hansen JM, et al. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia. 2008;28(3):226e236–226e236.
   Web of Science ®Google Scholar
• Khan S, Amin FM, Christensen CE, et al. Meningeal contribution to migraine pain: a magnetic resonance angiography study. Brain. 2019;142(1):93–102.
   PubMedGoogle Scholar
• Gokdemir MT, Nas C, Gokdemir GS. Pentraxin 3 level in acute migraine attack with aura: patient management in the emergency department. Am J Emerg Med. 2020;38(1):38–42.
   PubMed Web of Science ®Google Scholar
• Raddant AC, Russo AF. Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation. Expert Rev Mol Med. 2011;13:e36.
   PubMed Web of Science ®Google Scholar
• Pellesi L, Al-Karagholi MA, Chaudhry BA, et al. Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers. Cephalalgia. 2020;40(11):1212–1223.
   PubMed Web of Science ®Google Scholar
• Pellesi L, Al-Karagholi MA, De Icco R, et al. Effect of vasoactive intestinal polypeptide on development of migraine headaches: a randomized clinical trial. JAMA Netw Open. 2021;4(8):e2118543.
   PubMed Web of Science ®Google Scholar
• Theoharides TC, Donelan J, Kandere-Grzybowska K, et al. The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev. 2005;49(1):65–76.
   PubMedGoogle Scholar
• Iyengar S, Johnson KW, Ossipov MH, et al. CGRP and the trigeminal system in migraine. Headache. 2019;59(5):659e681–659e681.
   Web of Science ®Google Scholar
• Ashina M, Bendtsen L, Jensen R, et al. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain. 2000;86(1-2):133–138.
   PubMed Web of Science ®Google Scholar
• Ashina H, Schytz HW, Ashina M. CGRP in human models of primary headaches. Cephalalgia. 2018;38(2):353–360.
   PubMed Web of Science ®Google Scholar
• Cernuda-Morollón E, Larrosa D, Ramón C, et al. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology. 2013;81(14):1191–1196.
   PubMed Web of Science ®Google Scholar
• Latif R, Rafique N, Al Asoom L, et al. Diagnostic accuracy of serum calcitonin gene-related peptide and apolipoprotein E in migraine: a preliminary study. Int J Gen Med. 2021;14:851–856.
   PubMed Web of Science ®Google Scholar
• Kamm K, Straube A, Ruscheweyh R. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls. Cephalalgia. 2019;39(12):1535–1543.
   PubMed Web of Science ®Google Scholar
• Hansen JM, Hauge AW, Olesen J, et al. Calcitonin generelated peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia. 2010;30(10):1179–1186.
   PubMed Web of Science ®Google Scholar
• Juhasz G, Zsombok T, Modos EA, et al. NO-induced migraine attack: Strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain. 2003;106(3):461–470.
   PubMed Web of Science ®Google Scholar
• Juhasz G, Zsombok T, Jakab B, et al. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia. 2005;25(3):179e183–179e183.
   Web of Science ®Google Scholar
• Domínguez C, Vieites-Prado A, Pérez-Mato M, et al. CGRP and PTX3 as predictors of efficacy of onabotulinumtoxin type a in chronic migraine: an observational study. Headache. 2018;58(1):78–87.
   PubMed Web of Science ®Google Scholar
• Fan PC, Kuo PH, Chang SH, et al. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine. Cephalalgia. 2009;29(8):883–890.
   PubMed Web of Science ®Google Scholar
• Fan PC, Kuo PH, Lee MT, et al. Plasma calcitonin gene-related peptide: a potential biomarker for diagnosis and therapeutic responses in pediatric migraine. Front Neurol. 2019;10:10.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Lee SY, Cho S, et al. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal. J Headache Pain. 2018;19(1):53.
   PubMedGoogle Scholar
• Hansen JM, Ashina M. Calcitonin gene-related peptide and migraine with aura: a systematic review. Cephalalgia. 2014;34(9):695–707.
   PubMed Web of Science ®Google Scholar
• Schain AJ, Melo-Carrillo A, Stratton J, et al. CSD-Induced arterial dilatation and plasma protein extravasation are unaffected by fremanezumab: implications for CGRP's role in migraine with aura. J Neurosci. 2019;39(30):6001–6011.
   PubMed Web of Science ®Google Scholar
• Pérez-Pereda S, Toriello-Suárez M, Ocejo-Vinyals G, et al. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice. Mol Biol Rep. 2020;47(9):7125–7138.
   PubMed Web of Science ®Google Scholar
• Liu S, Qu X, Liu F, et al. Pentraxin 3 as a prognostic biomarker in patients with systemic inflammation or infection. Mediators Inflamm. 2014;2014:421429.
   PubMed Web of Science ®Google Scholar
• Ryu WS, Kim CK, Kim BJ, et al. Pentraxin 3: a novel and independent prognostic marker in ischemic stroke. Atherosclerosis. 2012;220(2):581–586.
   PubMed Web of Science ®Google Scholar
• Ceylan M, Bayraktutan OF, Becel S, et al. Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: association with migraine characteristics. Cephalalgia. 2016;36(6):518–525.
   PubMed Web of Science ®Google Scholar
• Gullo JdS, Bertotti MM, Silva CCP, et al. Hospital mortality of patients with severe traumatic brain injury is associated with serum PTX3 levels. Neurocrit Care. 2011;14(2):194–199.
   PubMed Web of Science ®Google Scholar
• Zhou C, Chen H, Zheng JF, et al. Pentraxin 3 contributes to neurogenesis after traumatic brain injury in mice. Neural Regen Res. 2020;15(12):2318–2326.
   PubMed Web of Science ®Google Scholar
• Tong M, Carrero JJ, Qureshi AR, et al. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2007;2(5):889–897.
   PubMed Web of Science ®Google Scholar
• Chu Y, Teng J, Feng P, et al. Pentraxin-3 in coronary artery disease: a meta-analysis. Cytokine. 2019;119:197–201.
   PubMed Web of Science ®Google Scholar
• Song J, Park DW, Moon S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the sepsis-3 definitions. BMC Infect Dis. 2019;19(1):968.
   PubMed Web of Science ®Google Scholar
• Tvedskov JF, Lipka K, Ashina M, et al. No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol. 2005;58(4):561–568.
   PubMed Web of Science ®Google Scholar